nsc 361456 has been researched along with Prostatic Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doroshow, J; Edelman, MJ; Grennan, T; Lauder, J; Meyers, FJ | 1 |
1 trial(s) available for nsc 361456 and Prostatic Neoplasms
| Article | Year |
|---|---|
Phase II trial of pyrazine diazohydroxide in androgen-independent prostate cancer.
Topics: Aged; Androgens; Antineoplastic Agents; Drug Resistance, Neoplasm; Humans; Male; Middle Aged; Prostatic Neoplasms; Pyrazines; Survival Rate | 1998 |